0001209191-22-018614.txt : 20220314 0001209191-22-018614.hdr.sgml : 20220314 20220314181207 ACCESSION NUMBER: 0001209191-22-018614 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220210 FILED AS OF DATE: 20220314 DATE AS OF CHANGE: 20220314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liao Carrie CENTRAL INDEX KEY: 0001899817 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40360 FILM NUMBER: 22738032 MAIL ADDRESS: STREET 1: C/O MIND MEDICINE INC. STREET 2: ONE WORLD TRADE CENTER, SUITE 8500 CITY: NEW YORK STATE: NY ZIP: 10007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc. CENTRAL INDEX KEY: 0001813814 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1166 ALBERNI STEET STREET 2: SUITE 1604 CITY: VANCOUVER STATE: A1 ZIP: V6E 3Z3 BUSINESS PHONE: (212) 220-6633 MAIL ADDRESS: STREET 1: 1166 ALBERNI STEET STREET 2: SUITE 1604 CITY: VANCOUVER STATE: A1 ZIP: V6E 3Z3 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-10 0 0001813814 Mind Medicine (MindMed) Inc. MNMD 0001899817 Liao Carrie C/O MIND MEDICINE (MINDMED), INC. ONE WORLD TRADE CENTER, SUITE 8500 NEW YORK NY 10007 0 1 0 0 VP, Controller&Acct Principal Subordinate Voting Shares 2022-02-10 4 A 0 403430 0.00 A 403430 D Stock Option (Right to Buy) 1.34 2022-02-10 4 A 0 524450 0.00 A 2027-02-09 Subordinate Voting Shares 524450 524450 D Grant of 403,430 restricted stock units ("RSUs") on February 10, 2022. Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. 25% of the RSUs will vest on October 21, 2022; the remaining RSUs granted will vest with 1/48th of the total shares vesting at the end of each month thereafter for the succeeding 36 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date. The option grant has an exercise price of $1.71 Canadian Dollars. This represents the exercise price in United States Dollars. 25% of the shares underlying the option shall vest and become exercisable on October 21, 2022; the remaining shares underlying the option shall vest and become exercisable with 1/48th of the total shares vesting at the end of each month thereafter for the succeeding 36 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date. /s/ Robert Barrow, Attorney-in-Fact 2022-03-14